Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.050
-0.010 (-0.33%)
At close: Oct 30, 2026, 4:00 PM EDT
3.061
+0.011 (0.34%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $16.5 million as of October 30, 2026. It is the 38,177th most valuable company in the world and the 5,304th biggest in the United States. Its market cap has increased by 52.85% in one year.
Market Cap
16.50M
Enterprise Value
-3.33M
1-Year Change
52.85%
Global Rank
Country Rank
#5,304 United States
Category
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $16.50M, an increase of 52.98%. That is a compound annual growth rate of 25.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 16.50M | -20.89% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 18.50M |
| Actuate Therapeutics | 18.43M |
| Seres Therapeutics | 17.78M |
| Context Therapeutics | 17.37M |
| Jasper Therapeutics | 17.31M |
| Marker Therapeutics | 16.34M |
| Pluri | 15.31M |
| Acumen Pharmaceuticals | 15.20M |